EARLY ACHIEVEMENT OF PARTIAL MAYO SCORE REMISSION AND IBDQ NORMALIZATION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY

Marc Ferrante  1     Brian G. Feagan  2     Chohee Yun  3     Jie Zhang  3     Laurent Peyrin-Biroulet  4     Severine Vermeire  4     Silvio Danese  5    
1 Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
2 Robarts Research Institute, Western University, London, ON, Canada
3 Gilead Sciences Inc., Foster City, CA, United States
4 Inflammatory Bowel Disease Unit, Nancy University Hospital, Nancy, France
5 IBD Center, Humanitas Research Hospital, Milan, Italy

Topic
IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing